753 related articles for article (PubMed ID: 29346042)
1. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline Summary.
Kindler HL; Ismaila N; Hassan R
J Oncol Pract; 2018 Apr; 14(4):256-264. PubMed ID: 29517955
[No Abstract] [Full Text] [Related]
3. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Popat S; Baas P; Faivre-Finn C; Girard N; Nicholson AG; Nowak AK; Opitz I; Scherpereel A; Reck M;
Ann Oncol; 2022 Feb; 33(2):129-142. PubMed ID: 34861373
[No Abstract] [Full Text] [Related]
4. Updates in the diagnosis and treatment of malignant pleural mesothelioma.
Katzman D; Sterman DH
Curr Opin Pulm Med; 2018 Jul; 24(4):319-326. PubMed ID: 29553973
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
6. Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?
Treasure T
Future Oncol; 2015; 11(24 Suppl):7-10. PubMed ID: 26638915
[TBL] [Abstract][Full Text] [Related]
7. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Daly ME; Singh N; Ismaila N; Antonoff MB; Arenberg DA; Bradley J; David E; Detterbeck F; Früh M; Gubens MA; Moore AC; Padda SK; Patel JD; Phillips T; Qin A; Robinson C; Simone CB
J Clin Oncol; 2022 Apr; 40(12):1356-1384. PubMed ID: 34936470
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Baas P; Fennell D; Kerr KM; Van Schil PE; Haas RL; Peters S;
Ann Oncol; 2015 Sep; 26 Suppl 5():v31-9. PubMed ID: 26223247
[No Abstract] [Full Text] [Related]
10. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
Schneider BJ; Ismaila N; Aerts J; Chiles C; Daly ME; Detterbeck FC; Hearn JWD; Katz SI; Leighl NB; Levy B; Meyers B; Murgu S; Nekhlyudov L; Santos ES; Singh N; Tashbar J; Yankelevitz D; Altorki N
J Clin Oncol; 2020 Mar; 38(7):753-766. PubMed ID: 31829901
[TBL] [Abstract][Full Text] [Related]
11. Malignant Mesothelioma: Has Anything Changed?
Kim RY; Sterman DH; Haas AR
Semin Respir Crit Care Med; 2019 Jun; 40(3):347-360. PubMed ID: 31525810
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatment of diffuse malignant pleural mesothelioma.
Zellos LS; Sugarbaker DJ
Semin Oncol; 2002 Feb; 29(1):41-50. PubMed ID: 11836668
[TBL] [Abstract][Full Text] [Related]
13. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma.
Nickell LT; Lichtenberger JP; Khorashadi L; Abbott GF; Carter BW
Radiographics; 2014 Oct; 34(6):1692-706. PubMed ID: 25310424
[TBL] [Abstract][Full Text] [Related]
14. Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.
Woolhouse I; Maskell NA
Thorax; 2018 Mar; 73(3):210-212. PubMed ID: 29444989
[No Abstract] [Full Text] [Related]
15. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
Multidisciplinary Committee of Oncology, Chinese Physicians Association
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
[TBL] [Abstract][Full Text] [Related]
16. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Stahel RA; Weder W; Lievens Y; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v126-8. PubMed ID: 20555061
[No Abstract] [Full Text] [Related]
17. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
Saddoughi SA; Abdelsattar ZM; Blackmon SH
Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
[TBL] [Abstract][Full Text] [Related]
18. Pathologic complete remission of malignant pleural mesothelioma after combined modality treatment: a case report.
Moubax K; Van Damme V; Nafteux P; Van den Heuvel M; Verbeken E; Lievens Y; Nackaerts K
Acta Clin Belg; 2013; 68(5):386-8. PubMed ID: 24579249
[TBL] [Abstract][Full Text] [Related]
19. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Khurshid H; Ismaila N; Bian J; Dabney R; Das M; Ellis P; Feldman J; Hann C; Kulkarni S; Laskin J; Manochakian R; Mishra DR; Preeshagul I; Reddy P; Saxena A; Weinberg F; Kalemkerian GP
J Clin Oncol; 2023 Dec; 41(35):5448-5472. PubMed ID: 37820295
[TBL] [Abstract][Full Text] [Related]
20. Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.
Odisio EG; Marom EM; Shroff GS; Wu CC; Benveniste APA; Truong MT; Benveniste MF
Semin Ultrasound CT MR; 2017 Dec; 38(6):559-570. PubMed ID: 29179896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]